Synthesis, structure and function of poly-alpha-amino acids--the simplest of protein models.
During the 1950s, linear and multichain poly-alpha-amino acids were synthesized by polymerization of the corresponding N-carboxyamino acid anhydrides in solution in the presence of suitable catalysts. The resulting homo- and heteropolymers have since been widely employed as simple protein models. Under appropriate conditions, poly-alpha-amino acids, in the solid state and in solution, were found to acquire conformations of an alpha-helix and of beta-parallel and antiparallel pleated sheets, or to exist as random coils. Their use in experimental and theoretical investigations of helix-coil transitions helped to shed new light on the mechanisms involved in protein denaturation. Conformational fluctuations of peptides in solution were analysed theoretically and studied experimentally by nonradiative energy-transfer techniques. Poly-alpha-amino acids played an important role in the deciphering of the genetic code. In addition, analysis of the antigenicity of poly-alpha-amino acids led to the elucidation of the factors determining the antigenicity of proteins and peptides. The synthetic procedures developed made possible the preparation of immobilized enzymes which were shown to be of considerable use as heterogeneous biocatalysts in the chemical and pharmaceutical industry. Interest in the biological and physicochemical characteristics of poly-alpha-amino acids was recently renewed because of the reported novel findings that some copolymers of amino acids are effective as drugs in multiple sclerosis, and that glutamine repeats and reiteration of other amino acids occur in inherited neurodegenerative diseases.
Katchalski-Katzir
E
E
Weizmann Institute of Science, Department of Membrane Research and Biophysics, Rehovot, Israel.
D000818:Animals; D000941:Antigens; D001704:Biopolymers / Q000737:chemistry; D018360:Crystallography, X-Ray; D004800:Enzymes, Immobilized / Q000378:metabolism; D005815:Genetic Code; D006801:Humans; D008958:Models, Molecular; D009103:Multiple Sclerosis / Q000188:drug therapy; D010455:Peptides / Q000138:chemical synthesis / Q000737:chemistry* / Q000276:immunology / Q000378:metabolism / Q000627:therapeutic use; D011487:Protein Conformation; D017433:Protein Structure, Secondary
D000941:Antigens; D001704:Biopolymers; D004800:Enzymes, Immobilized; D010455:Peptides; C021759:(T,G)-A-L